Products & Software
Urintel is an innovative application to help clinicians interpret urine screen immunoassay results. It eliminates the guesswork associated with unexpected results (false negatives/positives), generates a comprehensive medical record note, and provides justification for definitive testing by chromatography.
Naloxotel is an innovative application that helps clinicians stratify percent risk of opioid induced respiratory depression based on less that 20 y/n questions. It guides the clinician through an analysis that may qualify and justify patients for in-home naloxone, helps to select an appropriate dosage form (based on patient/caregiver need, cognition, and manual dexterity) and generates a comprehensive medical record note that memorializes risk assessment for opioid-induced respiratory depression, that such assessment was completed and that the patient (and/or caregiver) were made aware of opioid risks, offered, and if applicable, prescribed naloxone for in-home assess and use.
ORAtel is an innovative application that helps clinicians stratify percent risk of opioid induced respiratory depression based on less that 20 y/n questions. It also assesses the risk of opioid abuse and misuse. At the end, you can generate a chart note that you can copy and paste or save as PDF.
There are a number of new products in the pipeline. Some are in the early concept phase and others that are ready to be released soon. Learn more about these exciting products that are coming soon!